Design Therapeutics Inc (DSGN)

Design Therapeutics Inc (DSGN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $732M; returns 1 day -2.4%, 1 week -0.7%, 1 year +79.6%.

Design Therapeutics Inc. is a clinical-stage biopharmaceutical company pioneering a new class of small molecule therapies called GeneTAC (Gene Targeted Chimera) molecules.

Groups DSGN belongs to

• Clinical Stage Biotech
• Biotechnology
• Biopharmaceutical
• Healthcare
• Rare Diseases
• Life Sciences
• Gene Therapy
• Clinical Stage

DSGN financial model: income statement, cash flow and balance sheet